AAV with CMV-IVS promoter driven hChR2(C128S/D156A)-mCitrine
This AAV expresses hChR2(C128S/D156A)-mCitrine driven by an ubiquitous CMV-IVS promoter.
The CMV-IVS promoter is about 1.1 kb in length and consists of the commonly used CMV promoter/enhancer and the intron (IVS) from beta-globin . The presence of intron elements was shown to give a higher level of transgene expression than that of the original CMV promoter/enhancer.
hChR2 is a humanized version of ChR2 for mammalian expression. Wild-type ChR2, as well as a few of its mutations, provides the fastest excitation of the channelrhodopsins offered, and is widely used in in optogenetics techniques in neuroscience. hChR2(D156) mutant is another SFO mutation with a 6.9-minute open-state lifetime, and hChR2(C128S/D156A) double mutation creates a Stabilized Step Function Opsin (SSFO) with a stability of the active state up to 30 minutes.
Ready-to-use AAV expressing hChR2(C128S/D156A)-mCitrine driven by an ubiquitous CMV-IVS promoter. Available in AAV1, AAV2, AAV5, AAV6, AAV8, AAV9, AAV-DJ and other serotypes.